Ginsenosides: a potential natural medicine to protect the lungs from lung cancer and inflammatory lung disease
L Wang, Y Zhang, Z Song, Q Liu, D Fan, X Song - Food & Function, 2023 - pubs.rsc.org
Lung cancer is the malignancy with the highest morbidity and mortality. Additionally,
pulmonary inflammatory diseases, such as pneumonia, acute lung injury, chronic obstructive …
pulmonary inflammatory diseases, such as pneumonia, acute lung injury, chronic obstructive …
Metabolism-driven glycosylation represents therapeutic opportunities in interstitial lung diseases
K Drzewicka, Z Zasłona - Frontiers in Immunology, 2024 - frontiersin.org
Metabolic changes are coupled with alteration in protein glycosylation. In this review, we will
focus on macrophages that are pivotal in the pathogenesis of pulmonary fibrosis and …
focus on macrophages that are pivotal in the pathogenesis of pulmonary fibrosis and …
Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired DLCO
RM Smyth, MD James, SG Vincent, KM Milne… - Respiratory …, 2023 - rc.rcjournal.com
BACKGROUND: The precise mechanisms driving poor exercise tolerance in patients with
fibrotic interstitial lung diseases (fibrotic ILDs) showing a severe impairment in single-breath …
fibrotic interstitial lung diseases (fibrotic ILDs) showing a severe impairment in single-breath …
Physiological underpinnings of exertional dyspnoea in mild fibrosing interstitial lung disease
The functional disturbances driving “out-of-proportion” dyspnoea in patients with fibrosing
interstitial lung disease (f-ILD) showing only mild restrictive abnormalities remain poorly …
interstitial lung disease (f-ILD) showing only mild restrictive abnormalities remain poorly …
The gene expression of CALD1, CDH2, and POSTN in fibroblast are related to idiopathic pulmonary fibrosis
S Wu, M Liu, M Zhang, X Ye, H Gu, C Jiang… - Frontiers in …, 2024 - frontiersin.org
Introduction Idiopathic pulmonary fibrosis (IPF) is characterized by progressive lung
dysfunction due to excessive collagen production and tissue scarring. Despite recent …
dysfunction due to excessive collagen production and tissue scarring. Despite recent …
Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
S Tesolato, J Vicente-Valor, JR Jarabo, J Calatayud… - Biomedicines, 2023 - mdpi.com
Interstitial lung diseases (ILDs) constitute a group of more than 200 disorders, with idiopathic
pulmonary fibrosis (IPF) being one of the most frequent. Telomere length (TL) shortening …
pulmonary fibrosis (IPF) being one of the most frequent. Telomere length (TL) shortening …
Interstitial lung disease—From pulmonary perspective to pathogenesis, multidisciplinary approach and treatment.
CY Lee - International Journal of Rheumatic Diseases, 2023 - search.ebscohost.com
ILD encompasses constellations of diseases, including idiopathic etiology, autoimmune
etiology, exposure etiology, and miscellaneous lung diseases. Review: serum biomarkers of …
etiology, exposure etiology, and miscellaneous lung diseases. Review: serum biomarkers of …
[HTML][HTML] Progressive pulmonary fibrosis (PPF): Estimation of incidence and treatment rates in Japan using a claims database
Y Kondoh, T Ito, K Saito, H Bao, W Sakamoto - Respiratory Investigation, 2024 - Elsevier
Abstract Background Interstitial lung diseases (ILDs) are a heterogeneous group of
disorders, a subset of which develop progressive pulmonary fibrosis (PPF). There is little …
disorders, a subset of which develop progressive pulmonary fibrosis (PPF). There is little …
Elevated peripheral blood monocyte count is associated with prolonged postoperative hospitalization and functional decline in patients with interstitial lung diseases …
T Karampitsakos, T Milas, P Tsiri… - … Review for Medical …, 2024 - search.ebscohost.com
OBJECTIVE: Monocyte count and red cell distribution width (RDW) have shown prognostic
potential in patients with fibrotic lung diseases. Their kinetics and prognostic usefulness of …
potential in patients with fibrotic lung diseases. Their kinetics and prognostic usefulness of …
[HTML][HTML] Association of the 6-minute walking test ratio and difference with pulmonary function in patients with interstitial lung disease
R Yang, Y Wang, L Hao, G Zhao, X Liu - Saudi Medical Journal, 2023 - ncbi.nlm.nih.gov
Objectives: To examine the associations between 6-minute walk test (6MWT) and lung
functions, blood gas analysis findings, fractional exhaled nitric oxide (FeNO), and hospital …
functions, blood gas analysis findings, fractional exhaled nitric oxide (FeNO), and hospital …